News & Press Releases
< back to News & Press Releases| Date: Jun 04 2010 Lifetree Clinical Research® and Pain Clinic Chief Medical Director to Present in Dia Webinar |
|
|
NEWS RELEASE FOR IMMEDIATE RELEASE: June 2, 2010 FOR INFORMATION: Therese Clay, XO Marketing Group, (801) 541-9244, Email: therese@xomktg.com
LIFETREE CLINICAL RESEARCH® AND PAIN CLINIC CHIEF MEDICAL DIRECTOR TO PRESENT IN DIA WEBINAR
Salt Lake City – The chief medical director of Lifetree Clinical Research® and Pain Clinic, one of the largest specialized clinical research organizations in the Western region of the United States, will present in an upcoming Drug Information Association, Inc. (DIA) webinar. Lynn R. Webster, M.D. will present during the DIA webinar, entitled "Understanding the Development and Label Allowances for 505(b)(2) Abuse-Deterrent Products,” scheduled for Tuesday, June 8 from noon to 1:30 p.m. EDT. Featured topics include a discussion on the requirements abuse deterrent formulations must undergo to be approved by the FDA, and what these studies mean to labeling if the formulations are approved. The webinar moderator is Ken Phelps, president and CEO of Camargo Pharmaceutical Services, LLC. In addition to Dr. Webster, presenters from Camargo Pharmaceutical Services, LLC also include Chief Scientific Officer/Executive VP Ruth E. Stevens, Ph.D., MBA and Director, Clinical Services Cindy Phurrough. "Lifetree Clinical Research understands that leaders in the pharmaceutical industry recognize the need to develop painkillers that retain life-saving analgesia but reduce or preclude unwanted and potentially harmful effects. This is the most exciting area of research in the history of the industry,” said Lifetree Clinical Research CEO Alice Jackson. "Dr. Webster is highly respected and a published thought leader in the industry for his expertise in assessing patients for the risk of abuse, and he is a known national expert in pain and addiction medicine. Under his direction, Lifetree Clinical Research has become the leading specialized clinical research organization in abuse deterrent formulation. Lifetree Clinical Research® and its investigators are proud to be part of this life-saving trend in biopharmaceutical research.” The webinar is designed for professionals involved in drug product research and development, clinical research and development, research and development/strategic issues and regulatory affairs. Cost is $250 for an individual viewer with one Internet login, $799 for a group site registration allowing multiple viewers from one location and $995 for up to five Internet logins allowing one or more viewers at each login location. Interested participants should visit www.diahome.org and enter keyword 10230.
ABOUT LIFETREE CLINICAL RESEARCH Lifetree Clinical Research® offers multi-therapeutic clinical trials management (CTM) and site expertise in phase I-III clinical trials, with a unique approach to phase I, abuse liability, central nervous system and analgesia. Lifetree Clinical Research® is strategically integrated with Lifetree Pain Clinic in a seamless 25,000-square-foot, 60-bed facility and offers advanced expertise in first-in-human/MTD, bioavailability and bioequivalence, PK/PD/proof of concept, innovative pain model development and Cerebral Spinal Fluid sampling. Site services include PET Scanning, MRS and FMRI Capabilities and on-site pharmacy capable of handling all scheduled drugs I –V. For more detailed information about Lifetree Clinical Research®, please visit www.lifetreeresearch.com.
|



